- CEO
- Jiande Chen
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 190 Elgin Avenue George Town Cayman Islands 10177
- IPO Date
- Dec 10, 2021
- Business
- Healthcare AI Acquisition Corp. Healthcare AI Acquisition Corp. (HAIAU) operates as a blank check company, or special purpose acquisition company (SPAC), with no significant ongoing business operations; it focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting companies in the healthcare and pharmaceutical sectors, including e-Clinical solutions, healthcare information technology, and outsourced pharmaceutical services with high AI readiness and technological transformation potential. Incorporated in 2021 as a Cayman Islands exempted company and headquartered at 190 Elgin Avenue, George Town, Cayman Islands, the company is a subsidiary of Atticus Ale, LLC and maintains its principal executive offices in locations such as Dover, Delaware, or Albany, New York; it trades its units on Nasdaq under the ticker HAIAU, with separate Class A ordinary shares (HAIA) and warrants (HAIAW or HAIWF). Geographically, while the SPAC itself has no operations, it seeks targets with global potential, particularly in healthcare AI applications. In recent developments, Healthcare AI Acquisition Corp. entered into a definitive Business Combination Agreement on August 15, 2024, with Leading Group Limited, a licensed digital insurance broker and insurance channel specialist in China providing digital insurance brokerage, integrated marketing services, and tailored solutions to insurance carriers, individual policyholders, and corporate clients to enhance premium sales growth and customer acquisition; the transaction, valued at approximately $430 million for Leading Group with an additional $50 million private placement financing, contemplates a series of mergers where Leading Group shareholders will hold a majority of the combined company and appoint most directors, with completion originally targeted for Q4 2024 but repeatedly extended through shareholder approvals, including month-to-month deadlines to October 14, 2026, supported by monthly $0.10 per share deposits into trust and unsecured promissory notes to Leading Group for working capital. As of late 2025, the proposed merger remains pending shareholder and regulatory approvals, with the combined entity expected to list on Nasdaq and accelerate Leading Group's organic growth in China's insurance services market.